NIH-funded research R01 grant

Understanding chronic traumatic encephalopathy and related dementias

Official title: Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II

Funded at Boston University Medical Campus · NIH-10985074 · Data updated 2026-11-12

This study is looking at chronic traumatic encephalopathy (CTE) and similar types of dementia to understand how they develop and what factors might help protect against them, and it’s for people who want to learn more about their health through regular check-ups and tests like MRIs and blood work.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 15, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$3,289,394
NIH project number1R01NS139383-01
Project IDNIH-10985074 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include former athletes, particularly those who have experienced repetitive head impacts, as well as individuals with symptoms of dementia.

Less likely to help

Patients who have not been exposed to repetitive head impacts or do not exhibit symptoms of dementia may not benefit from this research.

What this research studies

This research investigates chronic traumatic encephalopathy (CTE) and related dementias by examining clinical presentations and biomarker profiles. It aims to identify risk and resilience factors associated with CTE, particularly focusing on social determinants of health. The study will involve longitudinal assessments, including clinical exams, MRI scans, and blood tests, to better understand how these conditions develop and progress over time. Participants will be followed up remotely to gather comprehensive data on their health.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnostic methods and treatment options for individuals affected by CTE and related dementias.

How similar studies have gone: Previous research has shown promise in identifying biomarkers for neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Alosco, Michael — Boston University Medical Campus
  • Study coordinator: Alosco, Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.